Latest filings (excl ownership)
No filings
Latest ownership filings
4
TCR2 THERAPEUTICS INC.
14 Feb 24
13F-NT
Notice of holdings reported by another manager
14 Feb 24
4
Rain Oncology Inc.
2 Feb 24
4
Rain Oncology Inc.
18 Dec 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
4
Rain Oncology Inc.
13 Oct 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
4
Rain Oncology Inc.
1 Jun 23
3
Rain Oncology Inc.
1 Jun 23
4
TCR2 THERAPEUTICS INC.
30 May 23
4
TCR2 THERAPEUTICS INC.
15 May 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
4
TCR2 THERAPEUTICS INC.
10 May 23
4
TCR2 THERAPEUTICS INC.
5 May 23
3
TCR2 THERAPEUTICS INC.
5 May 23
4
Jounce Therapeutics, Inc.
5 May 23
4
Jounce Therapeutics, Inc.
14 Mar 23
3
Jounce Therapeutics, Inc.
14 Mar 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
4
LA JOLLA PHARMACEUTICAL CO
24 Aug 22
4
LA JOLLA PHARMACEUTICAL CO
24 Aug 22
13F-HR
Quarterly holdings report by institutional manager
15 Aug 22
13F-HR
Quarterly holdings report by institutional manager
16 May 22
13F-HR
Quarterly holdings report by institutional manager
14 Feb 22
4
LA JOLLA PHARMACEUTICAL CO
14 Jan 22
4
LA JOLLA PHARMACEUTICAL CO
1 Dec 21
4
Aptevo Therapeutics Inc.
26 Nov 21
4
Aptevo Therapeutics Inc.
22 Nov 21
4
Odonate Therapeutics, Inc.
19 Nov 21
13F-HR
Quarterly holdings report by institutional manager
15 Nov 21
13F-HR
Quarterly holdings report by institutional manager
16 Aug 21
4
LA JOLLA PHARMACEUTICAL CO
1 Jun 21
4
LA JOLLA PHARMACEUTICAL CO
26 May 21
13F-HR
Quarterly holdings report by institutional manager
17 May 21
4
LA JOLLA PHARMACEUTICAL CO
4 May 21
13F-HR
Quarterly holdings report by institutional manager
16 Feb 21
5
HERON THERAPEUTICS, INC. /DE/
16 Feb 21
4
Michael S Hearne
23 Dec 20
13F-HR
Quarterly holdings report by institutional manager
16 Nov 20